Kelli Armstrong

637 total citations
5 papers, 469 citations indexed

About

Kelli Armstrong is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Kelli Armstrong has authored 5 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Kelli Armstrong's work include Heterotopic Ossification and Related Conditions (3 papers), Genetic Syndromes and Imprinting (2 papers) and Parathyroid Disorders and Treatments (2 papers). Kelli Armstrong is often cited by papers focused on Heterotopic Ossification and Related Conditions (3 papers), Genetic Syndromes and Imprinting (2 papers) and Parathyroid Disorders and Treatments (2 papers). Kelli Armstrong collaborates with scholars based in United States, United Kingdom and Germany. Kelli Armstrong's co-authors include Paul B. Yu, Agustin H. Mohedas, Alex N. Bullock, Xuechao Xing, Gregory D. Cuny, Jana Bagarova, Amy J. Wagers, Elisabeth M. W. Eekhoff, Sarah Hatsell and Devaveena Dey and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Science Translational Medicine.

In The Last Decade

Kelli Armstrong

5 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelli Armstrong United States 4 255 249 150 110 92 5 469
Julia Haupt Germany 10 286 1.1× 299 1.2× 202 1.3× 124 1.1× 156 1.7× 11 588
Ruth McCarrick-Walmsley United States 7 159 0.6× 172 0.7× 95 0.6× 66 0.6× 83 0.9× 8 397
Sho Tsukamoto Japan 10 190 0.7× 183 0.7× 103 0.7× 83 0.8× 65 0.7× 19 338
Florence A. Arts Belgium 8 173 0.7× 111 0.4× 121 0.8× 22 0.2× 32 0.3× 9 369
Amélie I. Velghe Belgium 9 128 0.5× 140 0.6× 117 0.8× 19 0.2× 30 0.3× 13 368
Salin A. Chakkalakal United States 9 524 2.1× 154 0.6× 326 2.2× 237 2.2× 199 2.2× 10 626
Charles J. Pruchno United States 11 74 0.3× 110 0.4× 84 0.6× 250 2.3× 123 1.3× 12 525
Takanao Sueyoshi Japan 8 69 0.3× 307 1.2× 36 0.2× 114 1.0× 64 0.7× 11 407
Elena Pipi United Kingdom 13 118 0.5× 66 0.3× 37 0.2× 25 0.2× 80 0.9× 19 495
Martin Judex Germany 11 233 0.9× 147 0.6× 29 0.2× 18 0.2× 37 0.4× 19 477

Countries citing papers authored by Kelli Armstrong

Since Specialization
Citations

This map shows the geographic impact of Kelli Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli Armstrong more than expected).

Fields of papers citing papers by Kelli Armstrong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli Armstrong. The network helps show where Kelli Armstrong may publish in the future.

Co-authorship network of co-authors of Kelli Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Kelli Armstrong. A scholar is included among the top collaborators of Kelli Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelli Armstrong. Kelli Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Hood, Tami, et al.. (2018). Abstract 808: Opportunity for therapeutic expansion in mantle cell lymphoma: Tazemetostat combination synergy status in preclinical MCL models. Cancer Research. 78(13_Supplement). 808–808. 2 indexed citations
2.
Chan-Penebre, Elayne, Kelli Armstrong, Allison E. Drew, et al.. (2017). Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models. Molecular Cancer Therapeutics. 16(5). 850–860. 127 indexed citations
3.
Dey, Devaveena, Jana Bagarova, Sarah Hatsell, et al.. (2016). Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Science Translational Medicine. 8(366). 366ra163–366ra163. 153 indexed citations
4.
Bagarova, Jana, Kelli Armstrong, Carol Lai, et al.. (2013). Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation. Molecular and Cellular Biology. 33(12). 2413–2424. 67 indexed citations
5.
Mohedas, Agustin H., Xuechao Xing, Kelli Armstrong, et al.. (2013). Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor. ACS Chemical Biology. 8(6). 1291–1302. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026